Yi Liu

5.7k total citations · 1 hit paper
172 papers, 4.1k citations indexed

About

Yi Liu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yi Liu has authored 172 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 86 papers in Cancer Research and 52 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yi Liu's work include Cancer-related molecular mechanisms research (60 papers), MicroRNA in disease regulation (47 papers) and Circular RNAs in diseases (35 papers). Yi Liu is often cited by papers focused on Cancer-related molecular mechanisms research (60 papers), MicroRNA in disease regulation (47 papers) and Circular RNAs in diseases (35 papers). Yi Liu collaborates with scholars based in China, United States and South Korea. Yi Liu's co-authors include Qizhan Liu, Xiaolin Lü, Fei Luo, Wenchao Xu, Chunhui Ni, Bairu Wang, Yue Xu, Le Shi, Fei Luo and Xinlu Liu and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Biomaterials.

In The Last Decade

Yi Liu

160 papers receiving 4.0k citations

Hit Papers

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis 2025 2026 2025 5 10 15 20 25
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
    2025 28 citations Luca Richeldi, Arata Azuma et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Liu China 36 2.7k 2.0k 836 370 367 172 4.1k
Juan Lü China 36 2.7k 1.0× 1.9k 1.0× 516 0.6× 712 1.9× 461 1.3× 143 4.1k
Hao Xu China 35 2.3k 0.9× 1.5k 0.8× 599 0.7× 476 1.3× 282 0.8× 126 3.5k
Weide Zhong China 40 2.8k 1.0× 1.7k 0.8× 1.1k 1.3× 879 2.4× 490 1.3× 217 4.7k
Hua Zhong China 22 2.6k 1.0× 2.6k 1.3× 550 0.7× 824 2.2× 424 1.2× 73 5.0k
Jia Li China 33 1.6k 0.6× 1.0k 0.5× 647 0.8× 577 1.6× 229 0.6× 138 3.1k
Yue Zhang China 39 3.1k 1.2× 1.7k 0.9× 518 0.6× 628 1.7× 359 1.0× 200 5.0k
Rong Tang China 23 1.9k 0.7× 1.0k 0.5× 1.0k 1.2× 620 1.7× 538 1.5× 100 3.5k
Jie Ding China 34 2.3k 0.9× 1.7k 0.9× 528 0.6× 506 1.4× 304 0.8× 120 3.9k

Countries citing papers authored by Yi Liu

Since Specialization
Citations

This map shows the geographic impact of Yi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Liu more than expected).

Fields of papers citing papers by Yi Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Liu. The network helps show where Yi Liu may publish in the future.

Co-authorship network of co-authors of Yi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Liu. A scholar is included among the top collaborators of Yi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Liu. Yi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yi, Yanbing Hou, Jingwen Fang, et al.. (2025). Landscape of extrachromosomal DNA characteristics in high-grade serous ovarian cancer via long-read sequencing. Cell Reports. 44(10). 116343–116343.
2.
Wang, Yue, Demin Cheng, Ziwei Li, et al.. (2025). Bazibushen attenuates fibroblast senescence in silica-induced pulmonary fibrosis via FOXO1/PINK1/Parkin Axis. Phytomedicine. 141. 156714–156714.
3.
Richeldi, Luca, Arata Azuma, Vincent Cottin, et al.. (2025). Initiation of Supplemental Oxygen in the FIBRONEER-IPF Trial of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7047–A7047.
4.
5.
Wang, Yang, et al.. (2025). KLF5 promotes esophageal squamous cell carcinoma radioresistance by targeting the Keap1-Nrf2 pathway. Discover Oncology. 16(1). 130–130. 2 indexed citations
6.
7.
Xu, Xiaolin, Yifan Wang, Yi Liu, et al.. (2024). Gut microbiota mediated T cells regulation and autoimmune diseases. Frontiers in Microbiology. 15. 1477187–1477187. 28 indexed citations
8.
Liu, Yi, Peide Li, Murali Ramaswamy, et al.. (2024). Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosis. BMC Pulmonary Medicine. 24(1). 468–468. 3 indexed citations
9.
Liu, Yi, et al.. (2024). The “double-edged sword effect” of nicotine. Fitoterapia. 177. 106102–106102.
10.
Liu, Yi, et al.. (2024). LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1. Archives of Biochemistry and Biophysics. 756. 110018–110018. 2 indexed citations
11.
Yun, Haiyang, Fengbiao Zhou, Christian Rohde, et al.. (2024). The landscape of RNA-chromatin interaction reveals small non-coding RNAs as essential mediators of leukemia maintenance. Leukemia. 38(8). 1688–1698. 3 indexed citations
12.
Li, Yanhong, Yubin Luo, Xiuping Liang, et al.. (2023). Proteomics: Potential techniques for discovering the pathogenesis of connective tissue diseases-interstitial lung disease. Frontiers in Immunology. 14. 1146904–1146904. 2 indexed citations
13.
Liu, Yi, Miaomiao Ye, Mengying Jiang, et al.. (2023). Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion. Cell Death and Disease. 14(9). 624–624. 15 indexed citations
14.
Wang, Sixuan, Jiangquan Liao, Yan Wang, et al.. (2023). Shengjie Tongyu Decoction Regulates Cardiomyocyte Autophagy Through Modulating ROS-PI3K/Akt/mTOR Axis by LncRNA H19 in Diabetic Cardiomyopathy.. PubMed. 29(6). 280–287. 7 indexed citations
15.
Hu, Panpan, et al.. (2022). The mechanism of the imbalance between proliferation and ferroptosis in pulmonary artery smooth muscle cells based on the activation of SLC7A11. European Journal of Pharmacology. 928. 175093–175093. 43 indexed citations
16.
17.
Liu, Yun, Rong Hu, Xiaowei Nie, et al.. (2021). The lncRNA PAHRF functions as a competing endogenous RNA to regulate MST1 expression by sponging miR-23a-3p in pulmonary arterial hypertension. Vascular Pharmacology. 139. 106886–106886. 14 indexed citations
18.
Du, Renle, Wenzhi Shen, Yi Liu, et al.. (2019). TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness. Signal Transduction and Targeted Therapy. 4(1). 60–60. 40 indexed citations
19.
Thangavel, Chellappagounder, Ettickan Boopathi, Yi Liu, et al.. (2018). Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non–Small Cell Lung Cancer. Clinical Cancer Research. 24(6). 1402–1414. 39 indexed citations
20.
Xia, Dan, et al.. (2014). Effect of 10-hydroxycamptothecin on functional bleb following antiglaucomatous filtering surgery. Zhonghua shiyan yanke zazhi. 32(2). 131–136. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Lü Breakdown of academic impact, for papers by Hao Xu Breakdown of academic impact, for papers by Weide Zhong Breakdown of academic impact, for papers by Hua Zhong Breakdown of academic impact, for papers by Jia Li Breakdown of academic impact, for papers by Yue Zhang Breakdown of academic impact, for papers by Rong Tang Breakdown of academic impact, for papers by Jie Ding
Rankless by CCL
2026